While potent corticosteroids are effective for gout flares, their systemic risks warrant exploring targeted therapies that could match their efficacy with a better safety profile. Preclinical data from a rat model of acute arthritis indicate that a novel, intra-articular slow-release formulation of colchicine exhibits efficacy comparable to that of dexa…
Keep reading with a 7-day free trial
Subscribe to Drug Development Executive to keep reading this post and get 7 days of free access to the full post archives.